Most LIMS implementations don’t fail because the software is wrong. They fail because the lab isn’t ready, and nobody told them what “ready” looks like.
By the time a go-live date is on the calendar, most lab directors have already spent months evaluating vendors, negotiating contracts, and reviewing feature demonstrations. What they haven’t done is the harder, less glamorous work: mapping every workflow exception that lives only in staff memory, auditing years of inconsistent test coding, or confirming in writing that their analyzer interface is supported. That work doesn’t happen in a sales cycle. It has to happen in the 60 days before go-live, or it surfaces on Day One, in production, with real patient samples.
The labs that went live without chaos were the ones that treated implementation as a project, not an event. This checklist is what that project looks like.
PRE-IMPLEMENTATION: The 30–60 Day Runway
Phase 1: Current-State Workflow Documentation (Days 1–14)
The first mistake most labs make is documenting how workflows are supposed to work. The SOP binder is not the truth. The truth is, the workaround that the night-shift tech does is because the SOP hasn’t been updated since the centrifuge was replaced, and the informal rule about what to do when a sample from a specific referring physician arrives without a requisition.
Map every clinical workflow from patient registration to result delivery, not the designed version, but the operational one. You need someone walking the floor, watching each station, asking, “What do you do when X happens?” That documentation is your configuration input.
At the same time, catalog every instrument interface you’re running: model, manufacturer, current protocol (ASTM, HL7), and whether the interface is bidirectional or unidirectional. Unidirectional interfaces that need to become bidirectional in the new system require interface builds; those take time, and you need to know now.
Audit your test menu completely: test codes, reference ranges, reportable units, autoverification rules, critical value thresholds, and reflex testing logic. All delta check parameters. Every auto-approval rule. These need to be configured in the new system, and if the source data is wrong, the configuration will be wrong.
Finally, pull all your current report templates. Flags that are standard and which have custom, client-specific layouts, state-required formats, and send-out reference ranges. Custom templates take build time. Count them.
Phase 2: Data Migration Scoping (Days 7–21)
The data migration question that matters most is not “can we migrate it?” But “should we migrate it?” Historical data migration is expensive, complex, and often responsible for a significant share of implementation delays and budget overruns. Make deliberate decisions about scope before your vendor starts quoting the migration effort.
Define what must come over: pending orders, active patient demographics, recent results (what time window?), and open QC records. Define what can be archived and accessed from the legacy system on a read-only basis. Most historical result data falls into the second category: queryable if you need it, but not worth migrating at cost.
Once the scope is defined, run a data quality audit on your legacy system. What you’ll find in most labs running LIS systems that are more than five years old: duplicate patient records (sometimes thousands), inconsistent test codes across locations, and result records with missing or corrupted fields. Every dirty record is a migration exception. Find them now, not during the cutover.
Pin down your migration cutover date and negotiate a parallel-run window with your vendor. The minimum acceptable parallel run is 5–7 business days, both systems running simultaneously, and results confirmed to match before exclusive operation in the new system begins. Labs that skip the parallel run and go directly to new-system-only are accepting unnecessary risk with patient data.
Phase 3: Integration Planning (Days 14–30)
Instrument interface support must be confirmed in writing, with interface build SLAs. “We support that analyzer” is not a confirmation. What you need is: which specific interface protocol will be used, who builds the interface (vendor or their partner), what the build timeline is, and what the acceptance testing process looks like. Get this in writing before your go-live date is set, otherwise, your go-live date may be set around an interface that isn’t finished.
Map all third-party integrations: EHR/EMR, billing platform, reference lab portals, payer systems, and patient portal. Each integration is a separate build and a separate go-live dependency. If your billing integration isn’t ready, you can’t bill on Day One. Prioritize accordingly.
Establish a staging environment with test data for each interface. Integration testing should happen in staging, repeatedly, before anything touches production. If your LIMS vendor doesn’t provide a staging environment for integration testing, that’s a question worth raising before you’ve signed the contract.
Phase 4: User and Role Configuration (Days 21–45)
Define all user roles and permission levels using RBAC principles, least privilege, not convenience. Front desk staff don’t need to access QC records. Phlebotomists don’t need to release results. Lab technicians don’t need billing data. Map your current staff to the new system’s role structure before go-live; don’t configure permissions on the fly after users start logging in.
QC rules, autoverification parameters, and critical value alert routing should all be configured and validated in staging, not on go-live day. This is the category of configuration that gets skipped when timelines compress. The lab goes live with default QC rules and placeholder autoverification thresholds, then spends the next six weeks cleaning up the downstream consequences.
Phase 5: Training Plan Execution (Days 30–60)
Role-based training, not department-wide training. Front desk registration staff, phlebotomists, bench technicians, supervisors, billing staff, and IT each need different training content. Running them through the same session wastes everyone’s time and leaves the bench tech uncertain about billing workflows that don’t apply to her job.
Train on real test cases in the staging environment. Hypothetical click-throughs don’t prepare staff for the actual workflow. A hematology tech needs to process a CBC panel, trigger a delta check, and follow the autoverification rule in the training environment before go-live. That’s what builds muscle memory.
Designate super users at each site. These are the staff members who get extended training and become the first call when a colleague is stuck. They are not IT. They are lab professionals who know the workflow and the system. Post go-live, the presence or absence of capable super users is usually the single biggest factor in how smooth the first 30 days feel.
GO-LIVE: The Critical 72 Hours
No surprises should emerge in the first 72 hours; every system and workflow should already have been tested in staging. The go-live checklist is a verification exercise, not a configuration exercise.
Before the first patient is registered in the new system, confirm:
- All instrument interfaces tested and confirmed bidirectional in the production environment (not staging)
- All QC rules and autoverification parameters validated in production
- All user accounts are active with confirmed access rights
- Critical value alert routing tested with a real test case
- Report delivery (fax, portal, email) tested with documented confirmation
- Billing integration confirmed with at least three test claims submitted and acknowledged
- Patient registration workflow completed end-to-end with a test patient
- Vendor on-call contact confirmed and distributed to all staff and site supervisors
Parallel Run Protocol
Run both the old and new systems simultaneously until the new system has processed at least 50 representative test types without discrepancy. Don’t shut down the legacy system on Day One. If you’re running a hybrid lab with multiple modalities, multiple collection sites, and 50 representative test types, it may take several days to accumulate. That’s expected. A week of parallel operation is not a failure of confidence in the new system. It’s a competent implementation.
POST-IMPLEMENTATION: The First 90 Days
Go-live is not the finish line. This is where the optimization begins, and where most implementation failures originate. The labs that struggle in the post-go-live period are usually the ones that didn’t have a structured plan for the first 90 days.
30-Day Post-Go-Live Checklist
- Identify and resolve all open instrument interface issues (there will be some)
- Review TAT data in the new system and compare it to your legacy baseline, specifically for high-volume panels and any test types with known variability
- Complete the first billing reconciliation cycle and confirm that the denial rate in the new system matches or improves on the legacy baseline; if denials are higher, investigate by CPT code immediately
- Complete the first supervisory QC review using the new system data
- Collect staff feedback systematically, a structured survey by role is better than anecdotal reports from the most vocal complainers
The 30 day mark is when instrument interface issues that weren’t caught during parallel running will surface. Budget time for them. They are normal. These are not a vendor failure or an implementation failure; they are the inevitable friction of connecting complex systems. The failure mode is not having a resolution process.
60-Day Optimization Review
At 60 days, compare actual usage against the configured workflow. What you’ll typically find: gaps between how the workflow was designed and how staff are using the system. A workaround has already emerged somewhere; find it before it becomes permanent. Analyze which autoverification rules are flagging for manual review at rates higher or lower than expected, and adjust parameters accordingly. Retrain where the gap indicates a training failure rather than a configuration problem.
90-Day Performance Baseline
By 90 days, you have enough production data to establish your new performance baseline. Set it. TAT by test type, QC failure rate, billing denial rate, and sample rejection rate; these are the numbers against which you’ll measure every operational improvement going forward. Labs that don’t establish this baseline at 90 days tend to lose track of where they started, which makes it impossible to demonstrate ROI on the implementation investment.
A LIMS ROI case isn’t built on configuration; it’s built on documented performance improvements over time. The 90-day baseline is where that documentation begins.
Implementation Is Not the Destination, It’s the Foundation
LIMS go-live is not the finish line. The value of the investment is realized in the operational improvements that become possible once the platform is live and your staff is proficient, faster TAT, cleaner autoverification, more accurate billing, real-time visibility into QC events and inventory. None of that is possible on Day One. It’s possible at Day 90, Day 180, Day 365, if the implementation was done right.
The checklist above is not a guarantee of a smooth go-live. No checklist is. But the labs that treat implementation as a planning project, not a vendor handoff, are the ones that reach that 90-day baseline without the backlog of unresolved issues, the staff resistance born of inadequate training, and the billing exceptions that linger for quarters because the integration was never properly tested.
